Charlie N Saunders1, Alex J Cornish2, Ben Kinnersley2, Philip J Law2, Richard S Houlston2. 1. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. Charlie.Saunders@icr.ac.uk. 2. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Abstract
BACKGROUND: The aetiology of glioma is poorly understood. Summary data from genome-wide association studies (GWAS) can be used in a Mendelian randomisation (MR) phenome-wide association study (PheWAS) to search for glioma risk factors. METHODS: We performed an MR-PheWAS analysing 316 phenotypes, proxied by 8387 genetic variants, and summary genetic data from a GWAS of 12,488 glioma cases and 18,169 controls. Causal effects were estimated under a random-effects inverse-variance-weighted (IVW-RE) model, with robust adjusted profile score (MR-RAPS), weighted median and mode-based estimates computed to assess the robustness of findings. Odds ratios per one standard deviation increase in each phenotype were calculated for all glioma, glioblastoma (GBM) and non-GBM tumours. RESULTS: No significant associations (P < 1.58 × 10-4) were observed between phenotypes and glioma under the IVW-RE model. Suggestive associations (1.58 × 10-4 < P < 0.05) were observed between leukocyte telomere length (LTL) with all glioma (ORSD = 3.91, P = 9.24 × 10-3) and GBM (ORSD = 4.86, P = 3.23 × 10-2), but the association was primarily driven by the TERT variant rs2736100. Serum low-density lipoprotein cholesterol and plasma HbA1C showed suggestive associations with glioma (ORSD = 1.11, P = 1.39 × 10-2 and ORSD = 1.28, P = 1.73 × 10-2, respectively), both associations being reliant on single genetic variants. CONCLUSIONS: Our study provides further insight into the aetiological basis of glioma for which published data have been mixed.
BACKGROUND: The aetiology of glioma is poorly understood. Summary data from genome-wide association studies (GWAS) can be used in a Mendelian randomisation (MR) phenome-wide association study (PheWAS) to search for glioma risk factors. METHODS: We performed an MR-PheWAS analysing 316 phenotypes, proxied by 8387 genetic variants, and summary genetic data from a GWAS of 12,488 glioma cases and 18,169 controls. Causal effects were estimated under a random-effects inverse-variance-weighted (IVW-RE) model, with robust adjusted profile score (MR-RAPS), weighted median and mode-based estimates computed to assess the robustness of findings. Odds ratios per one standard deviation increase in each phenotype were calculated for all glioma, glioblastoma (GBM) and non-GBM tumours. RESULTS: No significant associations (P < 1.58 × 10-4) were observed between phenotypes and glioma under the IVW-RE model. Suggestive associations (1.58 × 10-4 < P < 0.05) were observed between leukocyte telomere length (LTL) with all glioma (ORSD = 3.91, P = 9.24 × 10-3) and GBM (ORSD = 4.86, P = 3.23 × 10-2), but the association was primarily driven by the TERT variantrs2736100. Serum low-density lipoprotein cholesterol and plasma HbA1C showed suggestive associations with glioma (ORSD = 1.11, P = 1.39 × 10-2 and ORSD = 1.28, P = 1.73 × 10-2, respectively), both associations being reliant on single genetic variants. CONCLUSIONS: Our study provides further insight into the aetiological basis of glioma for which published data have been mixed.
Authors: E Susan Amirian; Georgina N Armstrong; Renke Zhou; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Michael E Scheurer; Kenneth Aldape; Irina Alafuzoff; Thomas Brännström; Helle Broholm; Peter Collins; Caterina Giannini; Marc Rosenblum; Tarik Tihan; Beatrice S Melin; Melissa L Bondy Journal: Am J Epidemiol Date: 2015-12-10 Impact factor: 4.897
Authors: Elisabeth Cardis; Lesley Richardson; Isabelle Deltour; Bruce Armstrong; Maria Feychting; Christoffer Johansen; Monique Kilkenny; Patricia McKinney; Baruch Modan; Siegal Sadetzki; Joachim Schüz; Anthony Swerdlow; Martine Vrijheid; Anssi Auvinen; Gabriele Berg; Maria Blettner; Joseph Bowman; Julianne Brown; Angela Chetrit; Helle Collatz Christensen; Angus Cook; Sarah Hepworth; Graham Giles; Martine Hours; Ivano Iavarone; Avital Jarus-Hakak; Lars Klaeboe; Daniel Krewski; Susanna Lagorio; Stefan Lönn; Simon Mann; Mary McBride; Kenneth Muir; Louise Nadon; Marie-Elise Parent; Neil Pearce; Tiina Salminen; Minouk Schoemaker; Brigitte Schlehofer; Jack Siemiatycki; Masao Taki; Toru Takebayashi; Tore Tynes; Martie van Tongeren; Paolo Vecchia; Joe Wiart; Alistair Woodward; Naohito Yamaguchi Journal: Eur J Epidemiol Date: 2007-07-18 Impact factor: 8.082
Authors: Debbie A Lawlor; Roger M Harbord; Jonathan A C Sterne; Nic Timpson; George Davey Smith Journal: Stat Med Date: 2008-04-15 Impact factor: 2.373
Authors: Beatrice S Melin; Jill S Barnholtz-Sloan; Margaret R Wrensch; Christoffer Johansen; Dora Il'yasova; Ben Kinnersley; Quinn T Ostrom; Karim Labreche; Yanwen Chen; Georgina Armstrong; Yanhong Liu; Jeanette E Eckel-Passow; Paul A Decker; Marianne Labussière; Ahmed Idbaih; Khe Hoang-Xuan; Anna-Luisa Di Stefano; Karima Mokhtari; Jean-Yves Delattre; Peter Broderick; Pilar Galan; Konstantinos Gousias; Johannes Schramm; Minouk J Schoemaker; Sarah J Fleming; Stefan Herms; Stefanie Heilmann; Markus M Nöthen; Heinz-Erich Wichmann; Stefan Schreiber; Anthony Swerdlow; Mark Lathrop; Matthias Simon; Marc Sanson; Ulrika Andersson; Preetha Rajaraman; Stephen Chanock; Martha Linet; Zhaoming Wang; Meredith Yeager; John K Wiencke; Helen Hansen; Lucie McCoy; Terri Rice; Matthew L Kosel; Hugues Sicotte; Christopher I Amos; Jonine L Bernstein; Faith Davis; Dan Lachance; Ching Lau; Ryan T Merrell; Joellen Shildkraut; Francis Ali-Osman; Siegal Sadetzki; Michael Scheurer; Sanjay Shete; Rose K Lai; Elizabeth B Claus; Sara H Olson; Robert B Jenkins; Richard S Houlston; Melissa L Bondy Journal: Nat Genet Date: 2017-03-27 Impact factor: 41.307
Authors: Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joe Wiemels; Ping Yang; John K Wiencke Journal: Nat Genet Date: 2009-07-05 Impact factor: 38.330
Authors: Louise A C Millard; Neil M Davies; Nic J Timpson; Kate Tilling; Peter A Flach; George Davey Smith Journal: Sci Rep Date: 2015-11-16 Impact factor: 4.379
Authors: Charlie N Saunders; Ben Kinnersley; Richard Culliford; Alex J Cornish; Philip J Law; Richard S Houlston Journal: Neuro Oncol Date: 2022-02-01 Impact factor: 12.300